Genmab reported impressive earnings with significant revenue growth driven by its key products, despite rising expenses.

Lucid Group (NASDAQ:LCID) is scheduled to announce Q3 earnings results on Thursday, November 7th, after market close. Wall ...

Hybe has revealed rocky Q3 2024 financials, including a nearly 19% YoY slip in recorded music revenue as well as a 98.6% YoY ...

Bipartisan bills including the Safeguarding Our Supply Chains Act and the Combating Organized Retail Crime Act of 2023 ...